Making smokers different with nicotine: NRT and quitting

International Journal of Drug Policy

Volumn 24, Issue 3, 2013, Pages 189-195

  Keane, Helen ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Actor network theory; Addiction; Nicotine; Nicotine replacement therapy; Smoking cessation

Indexed keywords

NICOTINE GUM; NICOTINE PATCH; NON PRESCRIPTION DRUG;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; GOVERNMENT; HARM REDUCTION; HUMAN; NICOTINE REPLACEMENT THERAPY; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; TREATMENT RESPONSE;

HARM REDUCTION; HUMANS; NICOTINE; NICOTINIC AGONISTS; PRACTICE GUIDELINES AS TOPIC; PSYCHOLOGICAL THEORY; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 84878112774     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.01.011     Document Type: Article

References (47)

1. Action on Smoking and Health Nicotine replacement therapy: Guidelines for healthcare professionals on using nicotine replacement therapy for smokers not yet ready to stop smoking 2007, http://www.quitsa.org.au/cms_resources/ASHNRTguide07.pdf (accessed 10.8.12).
2. Action on Smoking and Health (London) Nicotine Assisted Reduction to Stop (NARS) 2005, http://www.ash.org.uk/html/cessation/Smoking%20reduction/.NARS051014.pdf (accessed 10.8.12).
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) 2000, American Psychiatric Press, Washington, DC. 4th ed. text revision.
4. Asfar T., Ebbert J., Klesges R., Relyea G. Do smoking reduction interventions promote cessation in smokers not ready to quit?. Addictive Behaviors 2011, 36:764-768.
5. Bell K., Keane H. Nicotine control: E-cigarettes, smoking and addiction. International Journal of Drug Policy 2012, 23(3):242-247.
6. Berridge V. Histories of harm reduction: Illicit drugs, tobacco and nicotine. Substance Use & Misuse 1999, 34(1):35-47.
7. Bittoun R. A decade of over-the-counter therapeutic nicotine in Australia 2007, Brain & Mind Research Institute, Sydney.
8. Brandt A. From nicotine to nicotrol: Addiction cigarettes and American culture. Altering American consciousness 2004, 383-402. University of Massachusetts Press, Amherst. S. Tracy, C. Acker (Eds.).
9. Campbell N. Discovering addiction: The science and politics of substance abuse research 2007, University of Michigan Press, Ann Arbor.
10. Cancer Council of Australia Myths about smoking 2012, http://www.cancer.org.au/preventing-cancer/smoking-and-tobacco/myths-about-smoking.html#jump_3 (accessed 5.09.12).
11. Chapman S., MacKenzie R. The global research neglect of unassisted smoking cessation: Causes and consequences. PLoS Medicine 2010, 7(2):1-6.
12. Duff C. Reassembling (social) contexts: New directions for a sociology of drugs. International Journal of Drug Policy 2011, 22:404-406.
13. Elam M. Pharmaceutical incursion on cigarette smoking at the birth of the brain disease model of addiction. Critical perspectives on addiction 2012, 53-75. Emerald, Bingley. J. Netherland (Ed.).
14. Elam M., Gunnarson A. The advanced liberal logic of nicotine replacement and the Swedish invention of smoking as addiction. Transformations of the Swedish welfare state 2012, 137-152. Palgrave Macmillan, London. B. Larsson, M. Letell, H. Thorn (Eds.).
15. Etter J.-F., Stapleton J. Nicotine replacement therapy for long-term smoking cessation: A meta-analysis. Tobacco Control 2006, 15:280-285.
16. Fagerström K., Tejding R., Westin A., Lunell E. Aiding reduction of smoking with nicotine replacement medications?. Tobacco Control 1997, 6:311-316.
17. Foulds J., Veldheer S. Commentary on Etter & Bullen Could E-cigs become the ultimate nicotine maintenance device?. Addiction 2011, 106:2029-2030.
18. Gomart E. Methadone: Six effects in search of a substance. Social Studies of Science 2002, 32/1:93-135.
19. Gomart E. Towards generous constraint: Freedom and coercion in a French addiction treatment. Sociology of Health and Illness 2002, 24(5):517-549.
20. Gray N., Boyle P. The future of the nicotine addiction market. The Lancet 2003, 362:845-846.
21. Hammond D., Reid J., Driezen P., Cummings M., Borland R., Fong G., et al. Smokers' use of nicotine replacement therapy for reasons other than stopping smoking. Addiction 2008, 103:1696-1703.
22. Henningfield J. Nicotine medications for smoking cessation. The New England Journal of Medicine 1995, 333(18):1196-1203.
23. Hughes J., Shiffman S., Callas P., Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control 2003, 12:21-27.
24. Hyman S. Addiction: A disease of learning and memory. The American Journal of Psychiatry 2005, 162(8):1414-1422.
25. Jarvis M., Raw M., Russell M., Feyerabend C. Randomised controlled trial of nicotine chewing-gum. British Medical Journal 1982, 285:537-540.
26. Johnson & Johnson Nicorette icy white mad mouth 2009, (video file) http://www.youtube.com/watch?v=D5S-h4XKTWc (accessed 03.09.12).
27. Johnson & Johnson Nicorette (package and package insert) 2012.
28. Johnston L.M. Tobacco smoking and nicotine. Lancet 1942, (December):742.
29. Keane H. What's wrong with addiction? 2002, Melbourne University Press, Melbourne.
30. Latour B. Reassembling the social: An introduction to actor-network-theory 2005, Oxford University Press, Oxford.
31. Oster G., Delea T., Huse D., Regan M., Colditz G. The benefits and risks of over-the-counter availability of nicotine Polacrilex. Medical Care 1996, 34:389-402.
32. Parascandola M. Tobacco harm reduction and the evolution of nicotine dependence. American Journal of Public Health 2011, 101(4):632-641.
33. Pharmacia & Upjohn Nicotrol inhaler 1999, (video file) http://www.youtube.com/watch?v=cd63Rh52360&NR=1&feature=endscreen (accessed 03.09.12).
34. Prochaska J., DiClemente C. Stages and processes of self-change of smoking. Journal of Counselling and Clinical Psychology 1983, 51(3):390-395.
35. Quit Tasmania Quit because you can 2012, http://www.quittas.org.au/questions/faq/ (accessed 2.09.12).
36. Quit Victoria. (2012). (accessed 2.09.12). http://www.quit.org.au/.
37. Royal Australian College of General Practitioners Smoking Cessation Guidelines for Australian General Practice 2004, RACGP, Melbourne.
38. Royal College of Physicians Harm reduction in nicotine addiction: Helping people who can't quit 2007, RCP, London.
39. Shiffman S., Gitchell J., Pinney J., Burton S., Kemper K., Lara E. Public health benefit of over-the counter nicotine medications. Tobacco Control 1997, 6:306-310.
40. Shiffman S., Hughes J. Improving on the proven: Increased efficacy and reach with innovations in the use of therapeutic nicotine. Journal of Smoking Cessation, 4, special supplement 2010, 1-26.
41. Steinberg M., Schmelzer A., Richardson D., Foulds J. The case for treating tobacco dependence as chronic disease. Annals of Internal Medicine 2008, 148/7:555-556.
42. US Public Health Service The health consequences of smoking: Nicotine addiction: A report of the surgeon general 1988, US Department of Health and Human Services, Rockville.
43. Warner K. Tobacco harm reduction: Promise and perils. Nicotine and Tobacco Research 2002, S61-S71.
44. Warner K., Slade J., Sweanor D. The emerging market for long-term nicotine maintenance. Journal of the American Medical Association 1997, 278:1087-1092.
45. West R., Sohal T. 'Catastrophic' pathways to smoking cessation. British Medical Journal 2006, 332:458-460.
46. Zeller M., Hatsukami D. The strategic dialogue on tobacco harm reduction: A vision and blueprint for action in the US. Tobacco Control 2009, 18(4):324-332.
47. Zwar N., Richmond R., Borland R., Peters M., Litt J., Bell J., et al. Supporting smoking cessation: A guide for health professionals 2011, The Royal Australian College of General Practitioners, Melbourne.